BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND FLT3, STK1, 2322, ENSG00000122025, P36888, FLK2, CD135, RP11-153M24_3 AND Treatment
27515 results:

  • 1. Curcumin affects autophagy of prolactinoma cells by upregulating miR-206 to exert antitumor effects.
    Duan JF; Zhang QJ; Zhu J; Lu JH
    J Biochem Mol Toxicol; 2024 Jun; 38(6):e23734. PubMed ID: 38764151
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Palliative treatment of generalized metastatic follicular carcinoma of thyroid after operation: A case report and literature review.
    Zhao H; Kang W; Guan J; Wang Y
    Medicine (Baltimore); 2024 May; 103(20):e38237. PubMed ID: 38758843
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors.
    Lin AL; Rudneva VA; Richards AL; Zhang Y; Woo HJ; Cohen M; Tisnado J; Majd N; Wardlaw SL; Page-Wilson G; Sengupta S; Chow F; Goichot B; Ozer BH; Dietrich J; Nachtigall L; Desai A; Alano T; Ogilive S; Solit DB; Bale TA; Rosenblum M; Donoghue MTA; Geer EB; Tabar V
    Acta Neuropathol; 2024 May; 147(1):85. PubMed ID: 38758238
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Intelligent nanovesicle for remodeling tumor microenvironment and circulating tumor chemoimmunotherapy amplification.
    Huai M; Wang Y; Li J; Pan J; Sun F; Zhang F; Zhang Y; Xu L
    J Nanobiotechnology; 2024 May; 22(1):257. PubMed ID: 38755645
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Niraparib, Dostarlimab, and Bevacizumab as Combination Therapy in Pretreated, Advanced Platinum-Resistant Ovarian cancer: Findings From Cohort A of the OPAL Phase II Trial.
    Liu JF; Gaillard S; Wahner Hendrickson AE; Yeku O; Diver E; Gunderson Jackson C; Arend R; Ratner E; Samnotra V; Gupta D; Chung J; Zhang H; Compton N; Baines A; Bacqué E; Liu X; Felicetti B; Konecny GE
    JCO Precis Oncol; 2024 May; 8():e2300693. PubMed ID: 38754056
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Identification of necroptosis-related gene signatures for predicting the prognosis of ovarian cancer.
    Qin Y; Sheng Y; Ren M; Hou Z; Xiao L; Chen R
    Sci Rep; 2024 May; 14(1):11133. PubMed ID: 38750159
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Safety and efficacy of peptide receptor radionuclide therapy in neuroendocrine tumors: A single center experience.
    Sukrithan V; Armbruster H; Rogers S; Vogt SM; Grenade C; Verschraegen C; Zhou Y; Goyal A; Natwa M; Hussein A; Barr H; Konate D; Batdorf R; Brown A; Williams B; Zhao S; Wei L; Xu M; Shah MH; Konda B
    PLoS One; 2024; 19(5):e0298824. PubMed ID: 38748739
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Shikonin reduces M2 macrophage population in ovarian cancer by repressing exosome production and the exosomal galectin 3-mediated β-catenin activation.
    Wang M; Sun Y; Gu R; Tang Y; Han G; Zhao S
    J Ovarian Res; 2024 May; 17(1):101. PubMed ID: 38745186
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The Role of Palliative Surgery in the Management of Acute Intestinal Obstruction Secondary to Peritoneal Carcinomatosis.
    Bhat BK; Yadav A; Nundy S
    Chirurgia (Bucur); 2024 Apr; 119(2):218-226. PubMed ID: 38743835
    [No Abstract]    [Full Text] [Related]  

  • 10. [A rare cause of hypercorticism: ACTH-secreting pheochromocytoma (a case report)].
    Rifai K; Toulali F; Iraqi H; Ettaik M; Gharbi MEH
    Pan Afr Med J; 2024; 47():88. PubMed ID: 38737225
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Genomic Profiling of Rare Undifferentiated Sarcomatoid Subtypes of Pancreatic Carcinomas: In Search of Therapeutic Targets.
    Faber EB; Krause HB; Amin K; Walker P; Hosein PJ; Shields AF; Lenz HJ; Prakash A; Goel S; Oberley M; Malleo G; Luchini C; Hwang J; Florou V; Garrido-Laguna I; Lou E
    JCO Precis Oncol; 2024 May; 8():e2300595. PubMed ID: 38723231
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Overweight as a biomarker for concomitant thyroid cancer in patients with Graves' disease.
    Park J; An S; Bae JS; Kim JS; Kim K
    Front Endocrinol (Lausanne); 2024; 15():1382124. PubMed ID: 38711981
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Physical function as a predictor of chemotherapy-induced peripheral neuropathy in patients with pancreatic cancer.
    Lin KY; Chen PS; Lin CF
    BMC Gastroenterol; 2024 May; 24(1):154. PubMed ID: 38711006
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Active surveillance is a feasible and safe strategy in selected patients with papillary thyroid cancer and suspicious cervical lymph nodes detected after thyroidectomy.
    Solórzano M; Lustig N; Mosso L; Espinoza M; Santana R; Gonzalez H; Montero PH; Cruz F; Solar A; Domínguez JM
    Arch Endocrinol Metab; 2024 May; 68():e230146. PubMed ID: 38709151
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The prophylactic antiemetic therapies in management of differentiated thyroid cancer patients with radioactive iodine therapy: a single-center, non-randomized clinical trial.
    Li X; Cao J; Wang W; Zhu X; Sun Y; Song L; Zhang W; Han Y
    Front Endocrinol (Lausanne); 2024; 15():1310223. PubMed ID: 38706697
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Common hepatic artery lymph node metastasis in pancreatic ductal adenocarcinoma: an analysis of actual survival.
    Kuo S; Ventin M; Sato H; Harrison JM; Okuda Y; Qadan M; Ferrone CR; Lillemoe KD; Fernandez-Del Castillo C
    J Gastrointest Surg; 2024 May; 28(5):672-678. PubMed ID: 38704205
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Pituitary abscess: a descriptive analysis of a series of 19 patients-a multi-center experience.
    Xue Q; Shi X; Fu X; Yin Y; Zhou H; Liu S; Sun Q; Meng J; Bian L; Tan H; He H
    Eur J Med Res; 2024 May; 29(1):262. PubMed ID: 38698484
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Our experience with robotic-assisted thymic surgery.
    Podhráský M; Tvrdoň J; Schützner J
    Rozhl Chir; 2024; 103(2):40-47. PubMed ID: 38697812
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Impact of Bevacizumab on Clinical Outcomes in Patients With Platinum-resistant Relapsed Ovarian cancer.
    Seol A; Kim SI; Yoon HY; Lee M; Kim HS; Chung HH; Park NH; Song YS
    In Vivo; 2024; 38(3):1338-1350. PubMed ID: 38688599
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Failure to Undergo Resection Following Neoadjuvant Therapy for Resectable Pancreatic cancer: A Secondary Analysis of SWOG S1505.
    Cloyd JM; Colby S; Guthrie KA; Lowy AM; Chiorean EG; Philip P; Sohal D; Ahmad S
    J Natl Compr Canc Netw; 2024 Apr; 22(4):. PubMed ID: 38688309
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 1376.